Frontlight ResearchEarly access
CompletedNo phase
Prevalence of Postpartum Depression Among Patients of the CHUM GARE Clinic
Key facts
- Who runs it
- Centre hospitalier de l'Université de Montréal (CHUM)
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 100 people enrolled
- Started
- 20 Oct 2025
- Ended
- 1 Apr 2026
- Type of study
- Observational
- Record updated
- 6 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patients aged 18 years or more
- Patient who gave birth within the last 4 weeks to 6 months
- Ability to understand French or English and complete the EPDS questionnaire
- Physically present at their post-partum visit at the clinic
Who cannot take part
- Inability to comprehend and/or complete the EPDS
- Declines participation or does not provide informed consent
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Postpartum depression (PPD) is a frequent complication of the postnatal period but remains underdetected in routine clinical practice. This prospective clinical study, conducted at the high-risk pregnancy clinic of the CHUM, aims to estimate the prevalence of PPD among patients seen in postpartum follow-up. It also assesses the feasibility of implementing a standardized screening protocol that combines the administration of the Edinburgh Postnatal Depression Scale (EPDS) with a clinical decision-support algorithm to guide appropriate medical follow-up. The study also seeks to explore clinical characteristics associated with higher EPDS scores.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 6 July 2026